Ferris Capital’s Medicines Co MDCO Stock Holding History

Ferris Capital’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,000	Closed	-$1M	–	174
2019 Q3	$1M	Buy	20,000 +5,000	+33%	+$199K	0.36%	66
2019 Q2	$547K	Buy	+15,000	New	+$490K	0.2%	109

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Ferris Capital's MDCO Position: Q4 2019 in Review

Ferris Capital sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 20,000 shares — an estimated $1M sold.

Ferris Capital first reported a position in MDCO in Q2 2019 and held it in 2 quarters. The position peaked at $1M in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

Ferris Capital reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
Ferris Capital sold 20,000 Medicines Co shares in Q4 2019, an estimated $1M.
Ferris Capital first reported a position in Medicines Co in Q2 2019 and held it in 2 quarters.
Ferris Capital's Medicines Co position peaked at $1M in Q3 2019.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Ferris Capital's 13F filing for Q4 2019, filed 24 Jan 2020.